Table Filtering
Other Information
Release Statistics Download
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources July 29, 2024
Displaying entries 10451 - 10475 of 12216 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol ▲ FlyGlycoDB Evidence Code Names References
DOID:684 hepatocellular carcinoma SGD:S000000257 Saccharomyces cerevisiae S288C 852342 YBR053C
  • MGI:6194238
DOID:10534 stomach cancer SGD:S000000257 Saccharomyces cerevisiae S288C 852342 YBR053C
  • MGI:6194238
DOID:10579 leukodystrophy SGD:S000006008 Saccharomyces cerevisiae S288C 856018 YDC1
  • PMID:26792856
DOID:684 hepatocellular carcinoma SGD:S000006008 Saccharomyces cerevisiae S288C 856018 YDC1
  • MGI:6194238
DOID:0080547 metabolic dysfunction-associated steatohepatitis SGD:S000006008 Saccharomyces cerevisiae S288C 856018 YDC1
  • MGI:6194238
DOID:9870 galactosemia SGD:S000001253 Saccharomyces cerevisiae S288C 856617 YHR210C
  • MGI:6194238
DOID:9870 galactosemia SGD:S000005354 Saccharomyces cerevisiae S288C 855808 YNR071C
  • MGI:6194238
DOID:10579 leukodystrophy SGD:S000000387 Saccharomyces cerevisiae S288C 852481 YPC1
  • PMID:26792856
DOID:0080547 metabolic dysfunction-associated steatohepatitis SGD:S000000387 Saccharomyces cerevisiae S288C 852481 YPC1
  • MGI:6194238
DOID:684 hepatocellular carcinoma SGD:S000000387 Saccharomyces cerevisiae S288C 852481 YPC1
  • MGI:6194238
DOID:10591 pre-eclampsia SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:1240 leukemia SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:9870 galactosemia SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:0080909 castration-resistant prostate carcinoma SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:2349 arteriosclerosis SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:3910 lung adenocarcinoma SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:9970 obesity SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:684 hepatocellular carcinoma SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:0111773 46,XY sex reversal 8 SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:1612 breast cancer SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:0080630 B-lymphoblastic leukemia/lymphoma SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:8947 diabetic retinopathy SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:0060074 ductal carcinoma in situ SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:11612 polycystic ovary syndrome SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238
DOID:10534 stomach cancer SGD:S000002776 Saccharomyces cerevisiae S288C 851974 YPR1
  • MGI:6194238

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024